IL194735A - METHOD FOR SELECTING Stereo Selection of Morphinone History - Google Patents

METHOD FOR SELECTING Stereo Selection of Morphinone History

Info

Publication number
IL194735A
IL194735A IL194735A IL19473508A IL194735A IL 194735 A IL194735 A IL 194735A IL 194735 A IL194735 A IL 194735A IL 19473508 A IL19473508 A IL 19473508A IL 194735 A IL194735 A IL 194735A
Authority
IL
Israel
Prior art keywords
stereoselective reduction
morphinone
derivatives
morphinone derivatives
stereoselective
Prior art date
Application number
IL194735A
Other languages
English (en)
Hebrew (he)
Other versions
IL194735A0 (en
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38625648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL194735(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Publication of IL194735A0 publication Critical patent/IL194735A0/en
Publication of IL194735A publication Critical patent/IL194735A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
IL194735A 2006-04-21 2008-10-22 METHOD FOR SELECTING Stereo Selection of Morphinone History IL194735A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74533606P 2006-04-21 2006-04-21
PCT/US2007/009761 WO2007124114A2 (en) 2006-04-21 2007-04-19 Stereoselective reduction of a morphinone

Publications (2)

Publication Number Publication Date
IL194735A0 IL194735A0 (en) 2009-08-03
IL194735A true IL194735A (en) 2015-09-24

Family

ID=38625648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL194735A IL194735A (en) 2006-04-21 2008-10-22 METHOD FOR SELECTING Stereo Selection of Morphinone History

Country Status (13)

Country Link
US (2) US8183376B2 (cg-RX-API-DMAC7.html)
EP (1) EP2010539B1 (cg-RX-API-DMAC7.html)
JP (1) JP5586223B2 (cg-RX-API-DMAC7.html)
KR (1) KR101421747B1 (cg-RX-API-DMAC7.html)
CN (1) CN101466381B (cg-RX-API-DMAC7.html)
AU (1) AU2007240680B2 (cg-RX-API-DMAC7.html)
CA (1) CA2646313C (cg-RX-API-DMAC7.html)
ES (1) ES2629766T3 (cg-RX-API-DMAC7.html)
IL (1) IL194735A (cg-RX-API-DMAC7.html)
MX (1) MX2008013594A (cg-RX-API-DMAC7.html)
NZ (1) NZ572252A (cg-RX-API-DMAC7.html)
WO (1) WO2007124114A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200809258B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056500B2 (en) 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
CN1925875A (zh) * 2003-12-16 2007-03-07 尼克塔治疗亚拉巴马公司 化学改性的小分子
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
CN102014907A (zh) * 2008-05-07 2011-04-13 尼克塔治疗公司 外周作用阿片拮抗剂的口服给药
NZ589963A (en) * 2008-06-17 2011-08-26 Mallinckrodt Inc Processes for the preparation of 6- beta-hydroxy morphinan compounds
MX347741B (es) * 2008-09-16 2017-05-10 Nektar Therapeutics Opioides pegilados con bajo potencial de abuso.
AU2010239059B2 (en) 2009-04-24 2016-06-09 Brock University Processes for the preparation of morphinane and morphinone compounds
CA2936749C (en) 2010-06-11 2019-07-09 Rhodes Technologies Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof
TWI471289B (zh) 2010-06-11 2015-02-01 Rhodes Technologies 使三級胺進行n-脫烷反應之方法
SI2621496T2 (sl) 2010-09-30 2019-04-30 Astrazeneca Ab Kristalinični konjugat naloksol-PEG
CN103289075B (zh) * 2012-02-22 2016-01-20 天津键凯科技有限公司 聚乙二醇与纳洛酮的结合物及其药物组合物和应用
CA2886276A1 (en) 2012-10-30 2014-05-08 Nektar Therapeutics Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof
AU2015253417B2 (en) 2014-04-28 2020-02-20 Dimerx, Inc. Pharmaceutically active dimers linked through phenolic hydroxyl groups
WO2016028636A1 (en) * 2014-08-16 2016-02-25 Memorial Sloan Kettering Cancer Center Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methods
CN107033155B (zh) * 2016-02-04 2019-04-26 国药集团国瑞药业有限公司 一种吗啡酮类化合物的立体选择性还原方法
US11077103B2 (en) * 2016-11-23 2021-08-03 Aurobindo Pharma Ltd. Naloxegol oxalate and solid dispersion thereof
CN110305142B (zh) * 2019-07-12 2021-11-16 宜昌人福药业有限责任公司 一种6β-羟基吗啡衍生物的立体选择性合成方法
CN110330500B (zh) * 2019-07-12 2021-11-23 宜昌人福药业有限责任公司 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654756A (en) * 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2628962A (en) 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2715626A (en) 1950-07-05 1955-08-16 Merck & Co Inc Process of preparing dihydrocodeinone
US2649454A (en) 1951-08-20 1953-08-18 Univ California Method for preparing dihydromorphinone, dihydrocodeinone, and dihydropseudocodeinone
US2654746A (en) 1952-02-13 1953-10-06 Lilly Co Eli 1-dimethylamino-4-chloro-4-phenylbutane salt of penicillin
US2806033A (en) 1955-08-03 1957-09-10 Lewenstein Morphine derivative
US3254088A (en) 1961-03-14 1966-05-31 Lewenstein Morphine derivative
US3332950A (en) 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
DE2538075A1 (de) * 1975-08-27 1977-03-17 Boehringer Sohn Ingelheim N-tetrahydrofurfuryl-noroxymorphone, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
US4089855A (en) * 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
GB1593191A (en) * 1977-03-23 1981-07-15 Reckitt & Colmann Prod Ltd Derivatives of morphine
US4451470A (en) * 1982-07-06 1984-05-29 E. I. Du Pont De Nemours And Company Analgesic, antagonist, and/or anorectic 14-fluoromorphinans
US5208338A (en) 1991-06-14 1993-05-04 The United States Of America As Represented By The Department Of Health & Human Services. Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
DE4132159A1 (de) * 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
US5428159A (en) 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine
DE69507697T2 (de) * 1994-05-31 1999-06-10 Mallinckrodt Chemical, Inc., Chesterfield, Mo. Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US7056500B2 (en) 2001-10-18 2006-06-06 Nektar Therapeutics Al, Corporation Polymer conjugates of opioid antagonists
CN1925875A (zh) 2003-12-16 2007-03-07 尼克塔治疗亚拉巴马公司 化学改性的小分子

Also Published As

Publication number Publication date
CA2646313C (en) 2014-05-20
ES2629766T3 (es) 2017-08-14
US8563726B2 (en) 2013-10-22
US8183376B2 (en) 2012-05-22
KR101421747B1 (ko) 2014-07-30
MX2008013594A (es) 2009-01-16
AU2007240680B2 (en) 2013-05-02
CN101466381A (zh) 2009-06-24
EP2010539A2 (en) 2009-01-07
US20090221766A1 (en) 2009-09-03
WO2007124114A2 (en) 2007-11-01
AU2007240680A1 (en) 2007-11-01
EP2010539B1 (en) 2017-06-14
EP2010539A4 (en) 2010-06-02
NZ572252A (en) 2011-09-30
ZA200809258B (en) 2010-08-25
US20130018190A1 (en) 2013-01-17
IL194735A0 (en) 2009-08-03
HK1134903A1 (en) 2010-05-20
KR20080110910A (ko) 2008-12-19
JP5586223B2 (ja) 2014-09-10
CN101466381B (zh) 2012-11-14
CA2646313A1 (en) 2007-11-01
JP2009534393A (ja) 2009-09-24
WO2007124114A3 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
IL194735A0 (en) A method for stereoselective reduction of morphinone
PL1903019T3 (pl) Sposób wytwarzania izoolefin
EP1991964A4 (en) METHOD FOR PRODUCING ARCHITECTURAL SPACE OBJECTS
EP2060349A4 (en) METHOD FOR MANUFACTURING HOLE DISCHARGING
PL1992607T3 (pl) Sposób wytwarzania związku 4-oksochinolinowego
EP2086949A4 (en) PROCESS FOR THE PREPARATION OF BENZOXAZINES
EP2224807A4 (en) STEREOSELECTIVE REDUCTION METHODS
GB0605360D0 (en) Method of manufacture
ZA200904235B (en) Method for the enantioselective enzymatic reduction of secodione derivatives
EP2067606A4 (en) PHOTO PROCESS
GB0601849D0 (en) Method of maintaining software integrity
IL198589A0 (en) Method for producing 2-alkyl-3-aminothiophene derivative
HUE038415T2 (hu) Eljárás olajkötõ anyag elõállítására
EP1997812A4 (en) PROCESS FOR THE PREPARATION OF A CHINAZOLIN-4-ON DERIVATIVE
IL214972A0 (en) Method for stereoselectively and enzymatically reducing keto compounds
ZA200905055B (en) Method for the production of benzofuran-2-carboxamides
ZA200900636B (en) Method of prognosis
PT1925615E (pt) Processo de marcação com flúor 18 de derivados de tropano
EP2017254A4 (en) CRYSTALLIZATION PROCESS
EP1996736A4 (en) METHOD FOR STEEL MAKING
PL381401A1 (pl) Sposób wytwarzania o-etoksybenzamidu
IL202756A0 (en) Method for producing dioxazine derivatives
EP2100643A4 (en) PROCESS FOR MAKING COMPOUND METHYLATED FREE FROM DANGER
HU0600025V0 (en) Method for create of salt-cave
PL380363A1 (pl) Nowe pochodne disorbityloaminy i sposób ich otrzymywania

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed